GMI-2093

N/A

Report date: 2022/05/19 14:42:30
NME

Base Information

Drug NameGMI-2093
Drug Alias NameGMI2093
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescent Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrescent Biopharma Inc
Inactive CompaniesN/A
Active IndicationsFibrosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A